相关实验视频

Updated: Feb 8, 2026

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

抗蛋白吸附纳米蛋白质溶解针对奇美拉作为有效编程细胞死亡干1降解的强大平台

Xiang Lu^1,2,3, Shihui Song¹, Furui Qiu¹

¹School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, P. R. China.

|February 6, 2026

概括

一种新的无冠状病毒纳米-PROTACs平台 (CF-nPTs) 有效降解PD-L1,增强癌症免疫疗法. 这一突破克服了蛋白质冠状病毒障碍,导致显著的瘤回归,并在临床前模型中改善了生存率.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
免疫治疗是一种免疫疗法.

背景情况:

针对PD-1/PD-L1的免疫检查点阻塞 (ICB) 疗法显示出希望,但由于自适应性PD-L1上调而面临限制.
基于纳米粒子的蛋白质分解向嵌合体 (PROTACs) 提供直接的PD-L1降解,但蛋白质冠状形成阻碍了它们的有效性.
现有的纳米PROTAC面临非特异性蛋白质吸附的挑战,限制了目标参与和治疗潜力.

研究的目的:

开发一种无冠状病毒纳米-PROTACs平台 (CF-nPTs),可以克服蛋白质冠状病毒障碍,从而增强PD-L1降解.
调查CF-nPTs抵抗蛋白质吸附的能力,并提高目标参与度.
在临床前癌症模型中评估CF-nPTs的治疗疗效.

主要方法:

集成DSPE-PCB,一个zwitterionic防腐两动物,到状纳米-PROTACs创建一个冠状病毒免费的系统.
对CF-nPTs与现有的纳米-PROTAC平台 (Au,脂质体,体) 进行关于蛋白质吸附的比较分析.
评估PD-L1和E3酶核心招募,蛋白酶介导降解和淋巴结向.
在皮下黑色素瘤和淋巴结转移模型中评估瘤回归,生存延长和免疫激活.

主要成果:

CF-nPTs有效地抵抗非特异性蛋白质吸附,保持生物流体中的超清洁表面.
观察到PD-L1和E3酶的增强核心招募,导致高效的蛋白酶介导PD-L1降解.
无冠状病毒架构促进了强大的淋巴结向,放大了免疫治疗疗效.
在临床前模型中,CF-nPTs实现了明显的瘤回归,延长存活时间和强大的免疫激活.

结论:

蛋白-冠状病毒耐药性是决定纳米-PROTACs性能的一个关键因素.
CF-nPTs代表了有效的蛋白降解和增强癌症免疫治疗的有希望的平台.
这项研究为克服纳米-PROTACs开发的基本障碍建立了新的战略.

关键词:

在PD-L1中.抗蛋白冠状病毒的抗蛋白.免疫疗法免疫疗法淋巴结的目标是淋巴结.纳米-PROTACs 的使用.

更多相关视频

Tuning Degradation to Achieve Specific and Efficient Protein Depletion

Tuning Degradation to Achieve Specific and Efficient Protein Depletion

Published on: July 20, 2019

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Published on: April 23, 2017

相关概念视频

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

Regulated Protein Degradation

Regulated Protein Degradation

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...